Table 1.
Patient Characteristics
| Characteristics | Nondiabetics (n = 20) | Type 2 Diabetics (n = 20) | p |
|---|---|---|---|
| Age (years) | 70.1 ± 1.9 | 69 ± 1.6 | 0.34 |
| BMI (kg/m2) | 29 ± 1.1 | 30 ± 1.6 | 0.2 |
| Hypertension (%) | 15 (75) | 12 (60) | 0.5 |
| Dyslipidemia (%) | 19 (95) | 19 (95) | 1 |
| Former smoking (%) | 12 (60) | 15 (75) | 0.46 |
| Active smoking (%) | 2 (10) | 2 (10) | 1 |
| Blood glucose (mmol/L) | 5.61 ± 0.1 | 7.9 ± 0.5 | <0.001 |
| HbAIc (mmol/mol) | 39 ± 0.9 | 51 ± 3.6 | <0.001 |
| Total cholesterol (mmol/L) | 3.8 ± 0.2 | 3.7 ± 0.2 | 0.7 |
| LDL cholesterol (mmol/L) | 2 ± 0.2 | 1.8 ± 0.2 | 0.08 |
| HDL cholesterol (mmol/L) | 1 ± 0.1 | 1.1 ± 0.1 | 0.8 |
| Triglycerides (mmol/L) | 1 ± 0.1 | 1.8 ± 0.2 | 0.002 |
| Platelets (G/L) | 199 ± 11.4 | 181 ± 6.3 | 0.3 |
| Statins (%) | 20 (100) | 20 (100) | NS |
| Antiaggregant (%) | 20 (100) | 20 (100) | NS |
| Oral antidiabetics (%) | 0 | 18 (90) | <0.001 |
Results are expressed as means ± SEM. BMI, body mass index; HbA1c, glycosylated hemoglobin; LDL, low-density lipoprotein; HDL, high-density lipoprotein.